Dr. Garen Derhartunian, MD

Dr. Derhartunian practices at Elevate Health Group a Medical Corporation in Pasadena, California.

Dr. Derhartunian's NPI, 1609133776, was assigned on April 13, 2012. Dr. Derhartunian graduated from Ross University School of Medicine in 2012. Dr. Derhartunian holds California license A134914.

Dr. Derhartunian's primary practice is Elevate Health Group a Medical Corporation, at 150 Bellefontaine St, Pasadena, CA 91105 in Los Angeles County. The practice phone is (818) 246-8000.

Dr. Derhartunian's primary practice is Elevate Health Group a Medical Corporation in Pasadena, California. Dr. Derhartunian is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Axon Neurology. Dmand AI also links Dr. Derhartunian to 4 more hospitals, 5 home health agencies, 5 skilled nursing facilities, 3 group practices and clinics, 3 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Derhartunian practices, 19 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Derhartunian's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Derhartunian is board certified in internal medicine by the American Board of Internal Medicine. Dr. Derhartunian is licensed in California.

Dmand AI lists acid reflux, acute diabetes, acute gastroduodenitis, acute mini-stroke (TIA), acute respiratory failure, acute sinusitis, acute skin infection and adjustment disease among the conditions Dr. Derhartunian treats.

CMS data shows 6,502 Medicare services from Dr. Derhartunian across 33 procedure codes in 2024, for 1,316 Medicare patients. Medicare paid $453,999 for them.

CMS counts 1,316 Medicare patients who saw Dr. Derhartunian in 2024. The largest group is 65 to 74, with 508 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 62% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Derhartunian's median patient age at 43, with 55% women.

In 2024, Dr. Derhartunian wrote 17,739 Medicare Part D claims for 782 patients. 81% of them were for generic drugs. CMS names the drug for 16,902 of them, across 231 drugs with 11 or more claims each, at $2,128,519 in total drug cost. In 2023, CMS named 13,544 claims across 206 drugs.

Dr. Derhartunian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Derhartunian as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 84 general payments to Dr. Derhartunian from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $1,184.

Dr. Derhartunian graduated from Ross University School of Medicine in 2012.

Dr. Derhartunian is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.